Cencora, Inc.
COR
Key stats
- Open
- 352.95
- Day high
- 354.84
- Day low
- 348.68
- Previous close
- 349.88
- Volume
- 997.7K
- VWAP
- 349.72
- 52-week high
- 377.54
- 52-week low
- 244.82
- Market cap
- 66.77B
- Shares out
- 190.83M
- Employees
- 51,000
- Listed
- 1995
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices and global specialty drug logistics (World Courier). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · CONSHOHOCKEN, PA · cencora.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 2.3K
- Put open interest
- 2.0K
- Put/call
- 0.86
- At-the-money IV
- 26.7%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 320 call | 28.91 | Nov 10, 3:40 PM | 385 | 192 | 0.1% |
| 400 call | 0.30 | Oct 29, 2:22 PM | 20 | 34 | 51.7% |
| 370 call | 1.15 | Nov 10, 1:55 PM | 15 | 305 | 36.5% |
| 420 call | 0.90 | Aug 11, 2:37 PM | 13 | 22 | 80.8% |
| 340 call | 12.04 | Nov 12, 9:44 AM | 10 | 159 | 25.5% |
| 380 call | 2.37 | Nov 3, 3:23 PM | 5 | 324 | 36.8% |
Quarterly results
Massive · Aug 5, 2026| Q3 2026 to Jun 30, 2026 | Q2 2026 to Mar 31, 2026 | Q1 2026 to Dec 31, 2025 | Q4 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B |
| Gross profit | $3.61B | $3.59B | $3.07B | $2.95B |
| Operating income | $1.12B | $1.14B | $760.45M | $18.50M |
| Net income | $763.52M | $1.64B | $559.65M | −$339.70M |
| Diluted EPS | 3.94 | 8.40 | 2.87 | -1.74 |
| Operating cash flow | $2.65B | $1.34B | −$2.31B | $3.13B |
| Assets | $83.81B | $81.65B | $78.36B | $76.59B |
| Liabilities | $80.57B | $78.07B | $76.27B | $74.84B |
| Equity | $3.24B | $3.58B | $2.10B | $1.75B |
Technicals
Massive · Nov 12, 2026- 50-day average326.73
- 200-day average316.68
- RSI (14 days)60.8
Short interest
Massive · Oct 30, 2026- Oct 30, 20263.16M shares · 2.6 days to cover
- Oct 15, 20263.93M shares · 3.4 days to cover
- Sep 30, 20263.92M shares · 2.9 days to cover
- Sep 15, 20264.31M shares · 3.4 days to cover
Dividends
Massive · Nov 13, 2026- Ex Nov 13, 2026, paid Nov 30, 20260.6600 · 4 a year
- Ex Aug 14, 2026, paid Aug 31, 20260.6000 · 4 a year
- Ex May 15, 2026, paid Jun 1, 20260.6000 · 4 a year
- Ex Feb 13, 2026, paid Mar 2, 20260.6000 · 4 a year
- Ex Nov 14, 2025, paid Dec 1, 20250.6000 · 4 a year
- Ex Aug 15, 2025, paid Sep 3, 20250.5500 · 4 a year
- Ex May 16, 2025, paid Jun 2, 20250.5500 · 4 a year
- Ex Feb 14, 2025, paid Mar 3, 20250.5500 · 4 a year
Splits
Massive · Jun 16, 2009- Jun 16, 20092-for-1
- Dec 29, 20052-for-1
Related companies
MassiveNews coverage
No stories about Cencora, Inc. right now.